Murray Stahl's JNJ Position Overview
Murray Stahl (via Horizon Kinetics Asset Management LLC) currently holds 15,949 shares of Johnson & Johnson (JNJ) worth $3.3 M, representing 0.04% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Murray Stahl has maintained a long-term strategic position in JNJ, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2024, adding 2,849 shares. Largest reduction occurred in Q4 2020, reducing 4,323 shares.
Analysis based on 13F filings available since 2013 Q2
Murray Stahl's Johnson & Johnson (JNJ) Holding Value Over Time
Track share changes against reported price movement
Quarterly Johnson & Johnson (JNJ) Trades by Murray Stahl
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -231 | Reduce 1.43% | 15,949 | $206.95 |
| Q3 2025 | -3,122 | Reduce 16.17% | 16,180 | $185.42 |
| Q2 2025 | -310 | Reduce 1.58% | 19,302 | $152.75 |
| Q1 2025 | +10 | Add 0.05% | 19,612 | $165.84 |
| Q4 2024 | +174 | Add 0.90% | 19,602 | $144.62 |
| Q3 2024 | +2,849 | Add 17.18% | 19,428 | $162.06 |
| Q2 2024 | -601 | Reduce 3.50% | 16,579 | $146.16 |
| Q1 2024 | +50 | Add 0.29% | 17,180 | $158.19 |
| Q4 2023 | -465 | Reduce 2.64% | 17,130 | $156.74 |
| Q3 2023 | -201 | Reduce 1.13% | 17,595 | $155.75 |
| Q2 2023 | -17 | Reduce 0.10% | 17,796 | $165.52 |
| Q1 2023 | -878 | Reduce 4.70% | 17,813 | $155.00 |
| Q4 2022 | -77 | Reduce 0.41% | 18,691 | $176.65 |
| Q3 2022 | +175 | Add 0.94% | 18,768 | $163.36 |
| Q2 2022 | +39 | Add 0.21% | 18,593 | $177.49 |
| Q1 2022 | -19 | Reduce 0.10% | 18,554 | $177.21 |
| Q4 2021 | +1 | Add 0.01% | 18,573 | $171.05 |
| Q3 2021 | +1 | Add 0.01% | 18,572 | $161.48 |
| Q2 2021 | +34 | Add 0.18% | 18,571 | $164.72 |
| Q1 2021 | -804 | Reduce 4.16% | 18,537 | $164.32 |
| Q4 2020 | -4,323 | Reduce 18.27% | 19,341 | $157.39 |
| Q3 2020 | -1,296 | Reduce 5.19% | 23,664 | $148.88 |
| Q2 2020 | -24 | Reduce 0.10% | 24,960 | $140.62 |
| Q1 2020 | +695 | Add 2.86% | 24,984 | $131.12 |
| Q4 2019 | +396 | Add 1.66% | 24,289 | $145.87 |
| Q3 2019 | -1,164 | Reduce 4.65% | 23,893 | $129.37 |
| Q2 2019 | -339 | Reduce 1.33% | 25,057 | $139.28 |
| Q1 2019 | +392 | Add 1.57% | 25,396 | $139.79 |
| Q4 2018 | +1,203 | Add 5.05% | 25,004 | $129.06 |
| Q3 2018 | -432 | Reduce 1.78% | 23,801 | $138.19 |
| Q2 2018 | -224 | Reduce 0.92% | 24,233 | $121.32 |
| Q1 2018 | -61 | Reduce 0.25% | 24,457 | $128.14 |
| Q4 2017 | -100 | Reduce 0.41% | 24,518 | $139.69 |
| Q3 2017 | +412 | Add 1.70% | 24,618 | $129.99 |
| Q2 2017 | -113 | Reduce 0.46% | 24,206 | $132.32 |
| Q1 2017 | -2,586 | Reduce 9.61% | 24,319 | $124.55 |
| Q4 2016 | -1,743 | Reduce 6.08% | 26,905 | $115.18 |
| Q3 2016 | -1,974 | Reduce 6.45% | 28,648 | $118.12 |
| Q2 2016 | -152 | Reduce 0.49% | 30,622 | $121.32 |
| Q1 2016 | +833 | Add 2.78% | 30,774 | $108.21 |
| Q4 2015 | -238 | Reduce 0.79% | 29,941 | $102.74 |
| Q3 2015 | +338 | Add 1.13% | 30,179 | $93.34 |
| Q2 2015 | -833 | Reduce 2.72% | 29,841 | $97.45 |
| Q1 2015 | -708 | Reduce 2.26% | 30,674 | $100.57 |
| Q4 2014 | +64 | Add 0.20% | 31,382 | $104.58 |
| Q3 2014 | -365 | Reduce 1.15% | 31,318 | $106.58 |
| Q2 2014 | -646 | Reduce 2.00% | 31,683 | $104.63 |
| Q1 2014 | -285 | Reduce 0.87% | 32,329 | $98.21 |
| Q4 2013 | +1,400 | Add 4.49% | 32,614 | $91.59 |
| Q3 2013 | +412 | Add 1.34% | 31,214 | $86.69 |
| Q2 2013 | +30,803 | Add 0.00% | 30,802 | $85.87 |
Murray Stahl's Johnson & Johnson Investment FAQs
Murray Stahl first purchased Johnson & Johnson (JNJ) in Q2 2013, acquiring 30,802 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Murray Stahl has held Johnson & Johnson (JNJ) for 51 quarters since Q2 2013.
Murray Stahl's largest addition to Johnson & Johnson (JNJ) was in Q2 2013, adding 30,802 shares worth $2.64 M.
According to the latest 13F filing for Q4 2025, Murray Stahl's firm, Horizon Kinetics Asset Management LLC, owns 15,949 shares of Johnson & Johnson (JNJ), valued at approximately $3.3 M.
As of the Q4 2025 filing, Johnson & Johnson (JNJ) represents approximately 0.04% of Murray Stahl's publicly disclosed stock portfolio, making it one of their key holdings.
Murray Stahl's peak holding in Johnson & Johnson (JNJ) was 32,614 shares, as reported at the end of Q4 2013.